DORCHESTER WEALTH MANAGEMENT Co reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 18,980 shares of the healthcare conglomerate’s stock after selling 538 shares during the period. UnitedHealth Group comprises about 1.2% of DORCHESTER WEALTH MANAGEMENT Co’s holdings, making the stock its 28th largest position. DORCHESTER WEALTH MANAGEMENT Co’s holdings in UnitedHealth Group were worth $3,519,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Patriot Financial Group Insurance Agency LLC raised its position in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares during the period. Cribstone Capital Management LLC raised its position in shares of UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares during the period. Kings Point Capital Management raised its position in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares during the period. Founders Capital Management bought a new position in shares of UnitedHealth Group during the first quarter worth about $135,000. Finally, Parkside Financial Bank & Trust raised its position in shares of UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the period. Institutional investors and hedge funds own 86.37% of the company’s stock.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded down 1.25% on Thursday, reaching $192.40. 925,978 shares of the company traded hands. UnitedHealth Group Incorporated has a one year low of $132.39 and a one year high of $196.04. The firm’s 50 day moving average is $188.96 and its 200 day moving average is $174.38. The company has a market capitalization of $186.02 billion, a P/E ratio of 23.11 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter last year, the business earned $1.96 earnings per share. UnitedHealth Group’s revenue was up 7.7% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this news story can be accessed at https://www.watchlistnews.com/dorchester-wealth-management-co-has-3-52-million-stake-in-unitedhealth-group-incorporated-unh/1469432.html.

UNH has been the topic of a number of research reports. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 28th. Deutsche Bank AG reaffirmed a “buy” rating and set a $187.00 target price (up previously from $183.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $190.00 target price on shares of UnitedHealth Group in a research report on Monday, July 10th. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $205.00 target price (up previously from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. Finally, Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, May 19th. One investment analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $200.24.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the transaction, the director now owns 76,058 shares in the company, valued at $14,753,730.84. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the transaction, the director now owns 60,516 shares in the company, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Insiders sold 15,540 shares of company stock worth $2,873,320 in the last 90 days. 0.89% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.